1 research outputs found
Avelumab in paediatric patients with refractory or relapsed solid tumours: doseāescalation results from an openālabel, singleāarm, phase 1/2 trial
Avelumab in paediatric patients with refractory or relapsed solid tumours: doseāescalation results from an openālabel, singleāarm, phase 1/2 tria